Price change (24h):
0.09%
High (24h):
$0.02004934
Low (24h):
$0.01998252
Volume (24h):
$164.4
Market Cap:
$138.62K
All Time High:
99.29% $2.80
Dec 1, 2023
All Time Low:
122% $0.01
Jul 5, 2023
26.28 %(1Y)
$0.01998376
Price change (24h):
0.09%
High (24h):
$0.02004934
Low (24h):
$0.01998252
Volume (24h):
$164.4
Market Cap:
$138.62K
All Time High:
99.29% $2.80
Dec 1, 2023
All Time Low:
122% $0.01
Jul 5, 2023
Etica (ETI) launched in 2022. It is a domain-specific blockchain within the Decentralized Science (DeSci) movement, engineered exclusively for open source medical research divorced from intellectual property strictures.
Most biomedical research languishes behind paywalls and patent thickets. Etica assaults that model directly. The protocol archives medical data, trial methodologies, and analysis on an immutable ledger that no corporation or institution can gatekeep. It inverts the incentive structure of drug discovery—shifting rewards from monopoly pricing toward collaborative, publicly auditable scientific production.
Etica operates on its own blockchain using proof-of-work. This consensus architecture echoes the foundational cypherpunk logic of decentralized timestamping, where miners compete to append blocks containing verifiable research claims rather than mere account balances.
The network’s technical skeleton stays intentionally austere. A public code repository and dual block explorers—eticascan.org and explorer.etica-stats.org—expose every transaction and data entry. No Turing-complete smart contract layer obscures the ledger; the protocol uses a stripped-down scripting environment designed purely for anchoring scientific provenance hashes and protocol votes.
An anonymous author circulated the project’s whitepaper on the historic metzdowd.com cryptography mailing list in October 2019, the exact digital venue where Bitcoin’s whitepaper first materialized. The blockchain activated three years later, on April 17, 2022, following a deliberate and quiet build phase that avoided the airdrop mania and venture capital signaling endemic to the crypto cycle.
The protocol’s core mission is to dismantle the intellectual property machinery that delays cancer therapies, antibiotics, and rare disease treatments. It envisions a planetary-scale commons where medical knowledge flows frictionlessly from laboratory to clinic—verified, cited, and iterated upon without seeking permission from a patent holder.
ETI’s systematic role is entirely governance-driven. Token holders author and ratify protocol proposals that allocate research attention and compute cycles. Each vote is weighted by the quantity of ETI locked in a signaling contract, meaning resource allocation for medical inquiries funnels through token-based coordination rather than grant committees or corporate boards.
Holding ETI grants the power to direct the protocol’s research agenda. Entities that accumulate the token can push for clinical trials on neglected diseases or statistical reviews of existing drug data. Block rewards accrue to miners who execute proof-of-work, but the token’s utility for non-mining participants concentrates solely on voting influence over the open science roadmap.
Etica has a total supply of 6,753,276.53 tokens. Currently, 6,753,276.53 ETI are in circulation. With a market capitalization of $242,974.00, Etica ranks #4,550 among all cryptocurrencies.
| Date | Open | Close | High | Low |
|---|---|---|---|---|
| 11/07/2026 | $0.02 | $0.02 | $0.02 | $0.02 |
| 10/07/2026 | $0.02 | $0.02 | $0.02 | $0.02 |
| 09/07/2026 | $0.02 | $0.02 | $0.02 | $0.01 |
| 08/07/2026 | $0.02 | $0.02 | $0.02 | $0.01 |
| 07/07/2026 | $0.01 | $0.02 | $0.02 | $0.01 |
| 06/07/2026 | $0.02 | $0.01 | $0.02 | $0.01 |
| 05/07/2026 | $0.01 | $0.02 | $0.02 | $0.01 |
| 04/07/2026 | $0.01 | $0.01 | $0.01 | $0.01 |
AI trades 24/7 automatically Catch every opportunity
Zero-emotion algorithm Disciplined strategy
Passive income Set & forget automation
20,000+
traders trusted Stoic AI
$200M+
in cumulative assets under management since inception
2015
year of company foundation
Disclaimer:
This website is operated by Cindicator Ltd. (“Cindicator”), a Gibraltar private company. You are solely responsible for compliance with all laws that may apply to you and your use of Cindicator products. Cryptocurrencies and blockchain technologies have been the subject of scrutiny by regulatory bodies worldwide. With respect to your use of Cindicator products, Cindicator makes no representations regarding the applicability or compliance of its products with any laws or regulations, including, without limitation, those related to trading, options, derivatives, or securities. You also assume all legal, economic, and other risks related to your use of Cindicator products, including legal uncertainty, market volatility, and information security risks, among others. Trading in cryptocurrencies and digital assets is highly speculative, and the value of investments can fluctuate dramatically. You may lose a substantial portion or even all of your invested capital, and such trading may not be suitable for everyone. If you are unsure about these risks or your ability to bear potential losses, you should consult with an independent financial advisor before using Cindicator products. Depending on your jurisdiction, access to or use of Cindicator products may be subject to certain legal restrictions or prohibitions. You agree that it is solely your responsibility to determine and comply with any laws and regulations applicable to your use of Cindicator products, and that Cindicator is not responsible for informing you of such requirements.
Cindicator reserves the right to restrict or refuse access to its products for citizens or residents of certain jurisdictions, including those subject to international sanctions or other legal restrictions. All materials provided on this website (including any graphical materials regarding trading strategy performance or P&L) are presented solely for marketing and informational purposes. They do not guarantee any future profits and should not be construed as financial, investment, legal, or other professional advice. Cindicator is not a registered broker-dealer, investment adviser, or regulated financial institution, and the information and services provided do not constitute personal investment advice or a recommendation or offer to buy or sell any securities, cryptocurrencies, or other financial instruments. The information provided herein is summary in nature, does not purport to be complete, and is provided “as is” without any warranty as to its accuracy or completeness. All content may be updated or changed at any time without notice. Past performance is not indicative of future results. To the maximum extent permitted by law, Cindicator (including its directors, officers, and affiliates) shall not be liable for any loss or damage (direct, indirect, special, consequential, or incidental) arising from your use of Cindicator products, this website, or any information contained herein. Please read our Terms of Use for further details. If you do not agree with these terms, please close this site.